Olipudase alfa IgE-mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency. [PDF]
Pediatr Allergy ImmunolFiori L +6 more
europepmc +1 more source
Editorial: A new era in the treatment of food allergy. [PDF]
Front ImmunolUmetsu DT.
europepmc +1 more source
The effect of omalizumab treatment on inflammatory parameters in urticarial diseases: a retrospective study. [PDF]
Postepy Dermatol AlergolTemizel KA, Dursun P, Ikizoglu G.
europepmc +1 more source
Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhinitis. [PDF]
Front AllergyMiao Z +7 more
europepmc +1 more source
Rapid food desensitization supported by omalizumab, with adjunctive dupilumab for type 2 comorbidities: A pediatric case series. [PDF]
World Allergy Organ JGiavina-Bianchi P, Giavina-Bianchi B.
europepmc +1 more source
Immunochemical Determination of IgE and IgG Autoantibodies in Patients with Chronic Spontaneous Urticaria: A Narrative Review. [PDF]
Antibodies (Basel)Karachaliou CE, Livaniou E.
europepmc +1 more source
A case of eosinophilic dermatosis of hematologic malignancy treated with omalizumab. [PDF]
JAAD Case RepGhanshani R +6 more
europepmc +1 more source
Editorial: Clinical and molecular aspects of managing chronic urticaria: identifying endotypes, phenotypes, and factors determining responses and resistance to treatment. [PDF]
Front AllergySalman A +3 more
europepmc +1 more source
Advancements and challenges in the management of chronic inducible urticaria. [PDF]
Front ImmunolZhang M, Liu J, Zhi Y.
europepmc +1 more source
Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting. [PDF]
J Allergy Clin Immunol PractTseng H +4 more
europepmc +1 more source